From brain passage to cell adaptation: the road of human rabies vaccine development
- 1 November 2011
- journal article
- review article
- Published by Informa UK Limited in Expert Review of Vaccines
- Vol. 10 (11), 1597-1608
- https://doi.org/10.1586/erv.11.140
Abstract
A major challenge for global rabies prevention and control is the lack of sufficient and affordable high quality vaccines. Such candidates should be pure, potent, safe, effective and economical to produce, with broad cross-reactivity against viral variants of public health and veterinary importance. The history of licensed human vaccines reviewed herein demonstrates clearly how the field has evolved to the current state of more passive development and postexposure management. Modern cell culture techniques provide adequate viral substrates for production of representative verified virus seeds. In contrast to outdated nervous tissue-based rabies vaccines, once a suitable substrate is identified, production of high titer virus results in a major qualitative and quantitative difference. Given the current scenario of only inactivated vaccines for humans, highly cell-adapted and stable, attenuated rabies viruses are ideal candidates for consideration to meet the need for seed viruses in the future.Keywords
This publication has 81 references indexed in Scilit:
- Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheepVaccine, 2011
- Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of AdenoviridaeJournal of Virology, 2010
- Promising Rabies Vaccine for Postexposure Prophylaxis in Developing Countries, a Purified Vero Cell Vaccine Produced in ChinaClinical and Vaccine Immunology, 2010
- Characterization of a Single-Cycle Rabies Virus-Based Vaccine VectorJournal of Virology, 2010
- Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virusProceedings of the National Academy of Sciences, 2009
- Rabies DNA vaccine: No impact of MHC Class I and Class II targeting sequences on immune response and protection against lethal challengeVaccine, 2009
- An overview of animal cell substrates for biological productsBiologicals, 2008
- Nobel Prizes and the emerging virus conceptArchiv für die gesamte Virusforschung, 2008
- Impact of Globalization and Animal Trade on Infectious Disease EcologyEmerging Infectious Diseases, 2007
- Are all lyssavirus genes equal for phylogenetic analyses?Virus Research, 2007